FollowTheFilings

Managers Activity Compare Newest

Investment

ALNYLAM PHARMACEUTICALS INC

Historical 13F holders

CUSIP: 02043Q107
Type: Equity
Class: COM

Period	13F filings
2026 Q1	15
2025 Q4	17
2025 Q3	18
2025 Q2	13
2025 Q1	14
2024 Q4	14
2024 Q3	14

FollowTheFilings · Institutional 13F data room

All managers Activity Compare Newest filings X

Data is sourced from SEC EDGAR as filed. The SEC does not guarantee accuracy or completeness. Holdings exclude shorts and many derivatives; values are as of the report date.